Key Record Dates
ClinicalTrials.gov Identifier: | NCT04077463 |
---|---|
Brief Title: | A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer (Chrysalis-2) |
First Submitted : | August 30, 2019 |
First Submitted that Met QC Criteria : | August 30, 2019 |
First Posted : | September 4, 2019 |
Last Update Submitted that Met QC Criteria : | April 23, 2024 |
Last Update Posted : | April 24, 2024 |